
Cytokinetics schedules 2026 Annual Meeting May 27 with CEO performance overview.
Cytokinetics, a cardiovascular biopharmaceutical company, announced its 2026 Annual Meeting of Stockholders will be held on May 27 at its South San Francisco headquarters. CEO Robert I. Blum will present an overview of the company's performance immed...
